Project Grant HT94252610329
Award Date 7/1/26
Completion Date 6/30/28
Dollars Obligated $560K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- Federal Project Grant Award Summary The University of Pittsburgh received a $1.18 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, through August 31, 2028. This award supports research focused on overcoming immunotherapy resistance in acral melanoma, a specialized oncology research initiative aligned with the Defense Health Agency's mission to advance biomedical solutions for Service...
- Federal Project Grant Award Summary The University of Pittsburgh received a $1.8M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded May 1, 2026, with completion scheduled for April 30, 2029. This three-year research initiative focuses on unveiling mechanisms and developing innovative therapeutic approaches for ESR1-CCDC170 fusions in clinically aggressive, endocrine-resistant, and metastatic breast cancers. The...
- Federal Grant Award Summary The University of Pittsburgh received a $1.144M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. This research initiative addresses overcoming immunotherapy resistance in acral melanoma, a critical oncology research priority within the DHA's comprehensive portfolio of biomedical research initiatives. The grant supports hypothesis-driven...
- Federal Grant Award Summary The University of Pittsburgh received a $1.46M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for research on the intratumoral microbiome in acral melanoma. The award, initiated July 1, 2026 and concluding June 30, 2029, supports hypothesis-driven biomedical research designed to advance medical solutions and transform healthcare for service members and the American public. The research...
- Federal Grant Award Summary The University of Pittsburgh received a $300,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025, through September 30, 2027. The award supports research aimed at uncovering the nuclear antigens recognized by autoreactive T cells in systemic lupus erythematosus (SLE). This hypothesis-driven research initiative contributes to the DHA's broader mission of...
- Federal Grant Award Summary The University of Pittsburgh received a $986,228 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025 through May 31, 2029. The award supports research to identify and characterize pathways of progression from acute pancreatitis to recurrent acute pancreatitis and chronic pancreatitis. This research is designed to generate scientific knowledge and insights that advance...
- Federal Grant Award Summary The University of Pittsburgh received a $1,008,763 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate profilin-1's (Pfn1) role in chromophobe renal cell carcinoma (ChRCC) mitochondria and tumorigenesis. The award, effective September 1, 2025, through August 31, 2029, supports hypothesis-driven biomedical research designed to advance innovative medical solutions for critical health...
- Federal Grant Award Summary The University of Pittsburgh received a $2.67 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded August 15, 2025, with a completion date of August 14, 2029. The grant funds "A Collaborative Multiomic Approach to Pediatric Scleroderma (CMAPS) to Molecularly Characterize and Stratify Patients," a research initiative designed to advance the understanding and treatment of...
- Federal Grant Award Summary The University of Pittsburgh received a $434,722 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 15, 2025, with an ultimate completion date of August 14, 2029. The grant supports "A Collaborative Multiomic Approach to Pediatric Scleroderma" (CMAPS), a research initiative designed to molecularly characterize and stratify pediatric scleroderma patients. This four-year...
- Federal Project Grant Award Summary The University of Pittsburgh received a $2.45M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 30, 2025 through September 29, 2028. The award supports research on biomechanical and physiological resilience and recovery in load carriage, with work performed at the university's Pittsburgh, Pennsylvania facility. This research initiative aligns with the Defense Health...